Atlas Trials

Shanghai Jiaolian Drug Research and Development Co., Ltd

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shanghai Jiaolian Drug Research and Development Co., Ltd

RecordFirmDate
A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. (NCT06470191)Shanghai Jiaolian Drug Research and Development Co., Ltd2024-07-30
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) (NCT06413654)Shanghai Jiaolian Drug Research and Development Co., Ltd2024-07-17
A Clinical Study of B007 in the Treatment of Pemphigus. (NCT06454357)Shanghai Jiaolian Drug Research and Development Co., Ltd2024-07-12
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. (NCT06434610)Shanghai Jiaolian Drug Research and Development Co., Ltd2024-07-11
A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. (NCT06447597)Shanghai Jiaolian Drug Research and Development Co., Ltd2024-07-01
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy (NCT05668403)Shanghai Jiaolian Drug Research and Development Co., Ltd2023-03-02
Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer (NCT05555706)Shanghai Jiaolian Drug Research and Development Co., Ltd2022-12-06

Track Shanghai Jiaolian Drug Research and Development Co., Ltd automatically

Every clearance here is in the API, with alerts when new ones post.